Insurer Pledge to Streamline Prior Authorization Faces Scrutiny as Patients and Clinicians Report Little Improvement

One year after a high-profile announcement by the Trump administration, where dozens of health insurers pledged to reduce barriers to doctor-recommended care, a growing chorus of patients, advocates, and medical professionals claims that the promised reforms have fallen short, with some insurers now indicating they will not implement all the agreed-upon initiatives. The voluntary six-part pledge, aimed at overhauling the controversial prior authorization process, was hailed as a significant step forward. However, a year later, many affected by the system say their struggles have intensified, leading to skepticism about the pledge’s effectiveness and the true commitment of the insurance industry.

"It has never been this bad for patients," stated U.S. Rep. Greg Murphy (R-N.C.), a physician and co-chair of the GOP Doctors Caucus. His sentiment reflects a widespread frustration that the bureaucratic hurdles designed to control costs are instead hindering access to necessary medical treatment, often at a critical time for patients.

The Promise and the Reality of Prior Authorization Reform

The core of the June 2025 pledge was to reform prior authorization, a process that mandates patients or their healthcare providers obtain insurer approval before proceeding with many medical treatments, tests, and prescriptions. This requirement, insurers argue, is a crucial tool for managing costs, preventing waste and fraud, and ensuring patient safety. However, critics contend that it frequently delays or denies care, causing significant financial and emotional distress.

The health insurance industry trade group, AHIP (America’s Health Insurance Plans), reported that its member plans have eliminated approximately 6.5 million prior authorizations since the pledge was announced, representing an 11% reduction. AHIP spokesperson Chris Bond emphasized that "Prior authorization is a vital patient safeguard," asserting that the industry’s efforts are yielding tangible results.

However, this data has been met with considerable skepticism. Sally Nix, a patient advocate living with a chronic disease, described the voluntary pledge as "performative." Representative Murphy, who was present at the pledge’s announcement, echoed this sentiment, stating the agreement has "no teeth."

Sabrina Corlette, a research professor at the Center on Health Insurance Reforms at Georgetown University, offered a sobering perspective. She noted that voluntary insurer pledges have historically yielded limited improvements for patients. "In the absence of clear rules, policies, standards, and mandates," Corlette explained, "insurance companies are going to do what makes sense for them to do financially."

The Department of Health and Human Services (HHS), under whose auspices the pledge was announced, has not provided detailed responses to inquiries about its accountability mechanisms for the participating insurers. It remains unclear how, or if, the administration is actively monitoring and enforcing the commitments made in the pledge.

A Year of Unfulfilled Expectations

The prior authorization system, also known as preauthorization or precertification, has been a long-standing feature of health insurance. It is applied to a broad spectrum of services, from routine urgent care visits for conditions like tick bites to complex and costly cancer treatments. The insurance industry maintains that this process is essential for maintaining the financial stability of health plans and ensuring responsible use of healthcare resources.

The urgency for reform gained national attention in late 2024 following the killing of UnitedHealthcare CEO Brian Thompson. This tragic event ignited widespread public anger over insurance denials and the perceived tactics used by some insurers to prioritize profits over patient well-being. Patients and clinicians have become increasingly vocal about their experiences, highlighting the detrimental impact of prior authorization on care delivery.

Significantly, prior authorization reform has emerged as a rare area of bipartisan agreement in healthcare policy. On July 15, the House Ways and Means Committee unanimously advanced a bill that would impose new requirements on Medicare Advantage plans. This legislation would mandate that these plans provide the federal government with a list of all services subject to prior authorization and report data on denials and patient grievances, aiming to increase transparency and accountability.

When the industry pledge was announced in June 2025, then-administrator of the Centers for Medicare & Medicaid Services (CMS), Mehmet Oz, acknowledged the public outcry, noting, "There’s violence in the streets over these issues." He expressed hope for tangible results, stating, "Americans are upset about it."

Mike Gartner, founder of Health Access Innovation, an organization that assists patients in appealing insurance denials, remains doubtful about the sincerity of insurer changes. He argues that AHIP’s reported 11% reduction "hides a lot of nuance." Gartner specifically points out that patients requiring the most expensive treatments, such as those for cancer, continue to face disproportionate denials of doctor-recommended care.

AHIP clarified that its reported reduction pertains to medical services and does not include prescription medications. The trade group has not provided a detailed breakdown of which specific services have been removed from prior authorization requirements or how these reductions vary among individual insurers.

Last year, CMS officials indicated they would be "evaluating progress" and "driving accountability" regarding the pledge, even foreshadowing the creation of "public dashboards." However, no such dashboards have materialized, and federal officials have declined to comment on their enforcement strategies.

Representative Murphy reiterated his profound lack of trust in the industry’s self-regulation. "I didn’t believe insurance companies then," he stated, "and I don’t believe them now."

Case Studies: The Personal Toll of Insurance Hurdles

The abstract statistics and policy discussions often mask the deeply personal and often harrowing experiences of patients navigating the prior authorization labyrinth. The story of Betsy Adler and Justin Young of Stillwater, Minnesota, exemplifies these challenges. Days after their daughter Coco was born with a serious heart defect in February, the family received unexpected bills indicating significant out-of-network charges.

During Adler’s pregnancy, the family had switched to Medica, a Minnesota-based insurer that was among those that signed the industry pledge. Adler stated she had meticulously verified that her maternal-fetal specialists and hospital were in-network with Medica before their new plan took effect. However, the insurer began processing some claims as out-of-network, leading to over $4,000 in out-of-network charges on top of existing in-network bills.

When Adler, a psychotherapist, contacted Medica to resolve the issue, she was informed that a referral from her primary care provider had not been submitted. Her attempts to rectify the situation proved futile. At one point, Medica allegedly required her to obtain a referral from a clinic she had never visited. Subsequently, a Medica representative claimed the referral was never received, citing a malfunctioning fax machine.

"I have a critically ill child," Adler recalled thinking. "I can either spend my emotional energy at war with Medica, or I can let it go and just enjoy my time with my daughter." Medica spokesperson Greg Bury declined to comment on the specific case, citing patient privacy. He issued a statement affirming the company’s commitment to working with Adler to clarify her benefits and the insurer’s responsibilities.

One of the six promises made by insurers was to implement a 90-day grace period for "continuity of care" when patients switch insurance plans, effective January 1 of this year. This provision allows patients to continue receiving services and medications authorized under a previous insurer. However, Corlette of Georgetown University pointed out that the pledge’s language offers limited obligation. Insurers are not necessarily bound to honor another company’s network parameters. In Adler and Young’s case, Medica was not obligated to cover out-of-network providers as if they were in-network, even though they had been under their previous plan. The family ultimately switched insurance companies again when Coco was one month old to avoid further out-of-network costs.

Retroactive Denials and Opaque Justifications

Sally Nix, the patient advocate, also highlighted a significant loophole: the absence of explicit prohibitions against retroactive denials. Even when care is preapproved, insurers can later decide not to cover the costs. "Patients are going to see a lot more retroactive denials," Nix warned. She recently experienced this herself when her insurer approved, and then later denied, a claim for injections to treat her chronic nerve pain.

A similar situation unfolded for Jocelyn Austin, 49, of Amherst, New York. After developing an addiction to sleeping and anxiety medications prescribed over two decades, she underwent a several-week inpatient treatment for substance abuse last year. Her insurer, Independent Health, had approved the admission. Austin reported being substance-free since her discharge.

However, in December, the treatment facility billed Austin over $12,000, stating her insurer had not paid for the approved treatment. This was in addition to the $10,000 she had paid upfront to meet her out-of-network deductible. Crucially, Independent Health’s approval letters contained a disclaimer: "authorization is not a guarantee of claim payment."

Frank Sava, a spokesperson for Independent Health, stated that the denial was upheld because the services provided were deemed "inconsistent with the care that was authorized" and the "medical record did not sufficiently support what was billed." He added that these findings were reviewed and confirmed by an external consultant. An explanation of benefits from the insurer had indicated that the "provider," not the patient, was responsible for the cost of treatment. Despite this, the treatment facility has continued to pursue payment from Austin. She expressed her belief that "insurance companies should be held accountable."

Technological Hurdles and Shifting Commitments

Another key component of the insurer pledge involved adopting new technology to standardize the electronic submission of prior authorization requests. At the pledge’s announcement, CMS officials noted that over half of prior authorizations were still handled manually via phone, fax, or mail.

In April, AHIP provided an update on this technological initiative, outlining a phased adoption of new standards by participating insurers, with full implementation expected by January 1, 2027. However, KFF Health News learned that eight insurers, including prominent names like Alignment Health Plan, EmblemHealth, Independent Health, and Medica, did not sign onto this technology update in April. These insurers collectively serve beneficiaries across the country.

While these eight insurers declined interviews, most provided emailed statements asserting their continued commitment to prior authorization reform. Jerry Slowey, a spokesperson for Alignment Health, explained that their decision was due to concerns about the "transfer of confidential member health information through a non-standardized process involving third-party participation," suggesting such data sharing was not envisioned in the original commitment. Greg Bury of Medica stated that while the company supports standardization, the April update presented "a significant technical and operational hurdle that we are not able to commit to at this time." EmblemHealth later indicated they would sign onto the commitment after being questioned about their non-endorsement.

AHIP spokesperson Chris Bond expressed optimism that more plans would join the initiative, reiterating that health plans are "working continuously to implement their commitments." He acknowledged, however, that "there is still significant work ahead."

The pledge also included a commitment to enhance transparency and provide "clear, easy-to-understand explanations" to patients regarding coverage decisions, a standard already mandated by the Affordable Care Act. However, experts like Gartner observe that insurers frequently fail to adequately explain denials, providing communications that are often "inconsistent and contradictory." Both Gartner and Representative Murphy also raised concerns about the potential for insurers to increasingly utilize artificial intelligence to generate denials, stating, "They craft the pathways to basically deny things immediately with the hope that people will give up."

Representative Murphy expressed a desire for former President Donald Trump to issue executive orders addressing these issues, but acknowledged the formidable influence of the insurance industry’s lobbying efforts. "The problem is the insurance industry is the strongest lobby in this town," he concluded.

The experiences of patients like the Youngs and Austin, coupled with the skepticism of advocates and lawmakers, paint a picture of a system grappling with systemic issues. While the pledge represented a moment of potential progress, the reality on the ground suggests that the path to truly simplifying and improving access to care remains fraught with challenges, underscoring the need for robust regulatory oversight and accountability.